Globe Life Inc SEC Filings

Globe Life Inc. (GL) filed its Q2-25 Form 10-Q. Total assets rose 2.5% since YE-24 to $29.8 bn, driven by a $353 mm increase in invested assets to $19.9 bn and a $259 mm build in deferred acquisition costs. Shareholders’ equity improved to $5.42 bn from $5.31 bn as retained earnings increased $451 mm to $8.45 bn, partially offset by additional share repurchases (treasury stock up $394 mm, 16.2 mm shares held).

Policy liabilities grew 2.2% to $20.14 bn, with future policy benefits accounting for $18.85 bn. Debt remained essentially flat at $2.79 bn (short- and long-term combined), while the company’s cash position strengthened to $239 mm versus $165 mm at YE-24.

On the income side, premium revenue advanced 4.3% YoY to $1.22 bn for the quarter and 4.5% to $2.42 bn year-to-date. Net investment income ticked down 1.2% to $282 mm, and realized losses widened to $18.6 mm versus $12.6 mm a year earlier. Further earnings data were not provided in the excerpt. Common shares outstanding on 31 Jul 25 were 81.0 mm.

Globe Life Inc. (GL) – Form 4 insider activity

On 08/01/2025, EVP & Chief Strategy Officer Michael C. Majors exercised 10,000 employee stock options at an exercise price of $100.74. The newly issued shares were almost entirely sold the same day:

• Sales of 9,991 and 9 shares occurred within a $136.79–$137.78 range; weighted average disclosed at $137.41.
• Approximate gross proceeds: $1.37 million; option cost: $1.01 million.
• After the transactions, Majors holds 47,066 common shares directly, unchanged versus pre-exercise level.
• He retains 27,000 stock options (right to buy) expiring 02/26/2027.

No other equity or derivative movements were reported. The filing reflects a routine option exercise-and-sell transaction rather than an outright open-market purchase or disposal.

Globe Life Inc. (GL) – Form 4, filed 31-Jul-2025

Senior Vice-President & Chief Accounting Officer Michael Shane Henrie reported an option exercise and related sale on 29-Jul-2025:

• Option exercise (Code M): 3,250 shares at a $103.23 strike (grant dated 23-Feb-2025, expiry 23-Feb-2029).
• Open-market sale (Code S): 3,250 shares sold at a volume-weighted average price of $139.7526 (individual prices $139.67–$139.90).

Net effect on ownership

• Direct common stock declined from 6,290 to 3,040 shares (-3,250 shares).
• Indirect holdings remain 152.182 shares in the 401(k) plan.
• No remaining derivative securities from the exercised grant.

The transaction generated a spread of $36.52 per share between exercise price and sale price, indicating a gross pre-tax gain of roughly $0.12 million. Henrie continues to hold approximately 3.2 k direct shares plus 152 plan shares.

Globe Life Inc. (GL) – Form 144 notice of proposed insider sale

Executive Frank Svoboda intends to sell up to 25,000 common shares through Apex Clearing on or about 30 Jul 2025. The shares were obtained via stock-option exercise on 28 Feb 2019. Using the filing’s stated aggregate market value of $3.55 million, the transaction equals roughly 0.03 % of the 81.0 million shares outstanding.

Svoboda has already sold 30,000 shares in the past three months—15,000 on 20 May 2025 and 15,000 on 4 Jun 2025—realizing gross proceeds of $1.47 million. If the newly noticed sale is completed, total disposals would reach 55,000 shares over the May-July 2025 period.

Rule 144 filings are intent notices rather than confirmations; execution price and timing can change. Nevertheless, consecutive sales by a senior officer may influence investor sentiment, though the absolute amount is immaterial to share count.